menu search

MYNZ / Mainz Biomed to Participate in H.C. Wainwright Global Investment Conference and Equity Forum German Spring Conference

Mainz Biomed to Participate in H.C. Wainwright Global Investment Conference and Equity Forum German Spring Conference
BERKELEY, Calif. and MAINZ, Germany, May 17, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that members of its executive team will be participating in two notable investor conferences in May, 2022, the H.C. Wainwright Global Investment Conference and the Equity Forum German Spring Conference. Read More
Posted: May 17 2022, 03:01
Author Name: GlobeNewsWire
Views: 102232

MYNZ News  

Why Is Mainz Biomed (MYNZ) Stock Moving Today?

By InvestorPlace
November 1, 2023

Why Is Mainz Biomed (MYNZ) Stock Moving Today?

Mainz Biomed (NASDAQ: MYNZ ) stock is on the move Wednesday after the molecular genetics cancer diagnostic company shared results from a colorectal c more_horizontal

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology

By GlobeNewsWire
September 27, 2023

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology

Clinical trial evaluating the Company's novel mRNA biomarkers demonstrated sensitivity for colorectal cancer of 94% with specificity of 97% and advanc more_horizontal

Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference

By GlobeNewsWire
September 20, 2023

Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference

BERKELEY, Calif. and MAINZ, Germany, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a m more_horizontal

Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference

By GlobeNewsWire
August 29, 2023

Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference

Company Anticipates Read Outs of the Clinical Data from its EU and US Feasibility Studies this September and in Q4 Company Anticipates Read Outs of th more_horizontal

Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23

By GlobeNewsWire
March 21, 2023

Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23

BERKELEY, Calif. and MAINZ, Germany, March 21, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a mol more_horizontal

Mainz Biomed to Present at the H.C. Wainwright Annual Global Investment Conference

By GlobeNewsWire
September 1, 2022

Mainz Biomed to Present at the H.C. Wainwright Annual Global Investment Conference

BERKELEY, Calif. and MAINZ, Germany, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a m more_horizontal

Mainz Biomed to Participate in H.C. Wainwright Global Investment Conference and Equity Forum German Spring Conference

By GlobeNewsWire
May 17, 2022

Mainz Biomed to Participate in H.C. Wainwright Global Investment Conference and Equity Forum German Spring Conference

BERKELEY, Calif. and MAINZ, Germany, May 17, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a mol more_horizontal

Why Mainz Biomed Stock Is Crashing Today

By The Motley Fool
January 26, 2022

Why Mainz Biomed Stock Is Crashing Today

The molecular genetics diagnostic company announced the pricing of a follow-on stock offering. more_horizontal


Search within

Pages Search Results: